HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build Unknown region code '840'

HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions

: Hepatitis C Procedures Codes - TTL Representation

Draft as of 2024-08-12

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "nachc-b2-de113"] ; # 
  fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet nachc-b2-de113</b></p><a name=\"nachc-b2-de113\"> </a><a name=\"hcnachc-b2-de113\"> </a><a name=\"nachc-b2-de113-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-hiv-custom.html\"><code>http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE113\">NACHC.B2.DE113</a></td><td>RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C)</td><td>Hepatitis C Procedures - RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE114\">NACHC.B2.DE114</a></td><td>Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C)</td><td>Hepatitis C Procedures - Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE115\">NACHC.B2.DE115</a></td><td>Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C)</td><td>Hepatitis C Procedures - Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE116\">NACHC.B2.DE116</a></td><td>Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)</td><td>Hepatitis C Procedures - Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE117\">NACHC.B2.DE117</a></td><td>Hepatitis C screening documented as performed (HIV)</td><td>Hepatitis C Procedures - Hepatitis C screening documented as performed (HIV)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE118\">NACHC.B2.DE118</a></td><td>Patient receiving antiviral treatment for Hepatitis C (HEP-C)</td><td>Hepatitis C Procedures - Patient receiving antiviral treatment for Hepatitis C (HEP-C)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE119\">NACHC.B2.DE119</a></td><td>Collection of venous blood by venipuncture</td><td>Hepatitis C Procedures - Collection of venous blood by venipuncture</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE120\">NACHC.B2.DE120</a></td><td>Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver</td><td>Hepatitis C Procedures - Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver</td></tr></table></li></ul></div>"
  ] ; # 
  fhir:url [ fhir:v "http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-b2-de113"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "HepatitisCProceduresCodes"] ; # 
  fhir:title [ fhir:v "Hepatitis C Procedures Codes"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:experimental [ fhir:v "false"^^xsd:boolean] ; # 
  fhir:date [ fhir:v "2024-08-12T19:50:21+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "National Association of Community Health Centers, Inc. (NACHC)"] ; # 
  fhir:contact ( [
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://www.nachc.org/" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Codes representing possible values for the Hepatitis C Procedures element"] ; # 
  fhir:jurisdiction ( [
    ( fhir:coding [
fhir:system [ fhir:v "http://unstats.un.org/unsd/methods/m49/m49.htm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "840" ]     ] )
  ] ) ; # 
  fhir:immutable [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:copyright [ fhir:v "Copyright National Association of Community Health Centers, Inc. (NACHC)"] ; # 
  fhir:compose [
    ( fhir:include [
fhir:system [ fhir:v "http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom"^^xsd:anyURI ] ;
      ( fhir:concept [
fhir:code [ fhir:v "NACHC.B2.DE113" ] ;
fhir:display [ fhir:v "RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C)" ]       ] [
fhir:code [ fhir:v "NACHC.B2.DE114" ] ;
fhir:display [ fhir:v "Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C)" ]       ] [
fhir:code [ fhir:v "NACHC.B2.DE115" ] ;
fhir:display [ fhir:v "Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C)" ]       ] [
fhir:code [ fhir:v "NACHC.B2.DE116" ] ;
fhir:display [ fhir:v "Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)" ]       ] [
fhir:code [ fhir:v "NACHC.B2.DE117" ] ;
fhir:display [ fhir:v "Hepatitis C screening documented as performed (HIV)" ]       ] [
fhir:code [ fhir:v "NACHC.B2.DE118" ] ;
fhir:display [ fhir:v "Patient receiving antiviral treatment for Hepatitis C (HEP-C)" ]       ] [
fhir:code [ fhir:v "NACHC.B2.DE119" ] ;
fhir:display [ fhir:v "Collection of venous blood by venipuncture" ]       ] [
fhir:code [ fhir:v "NACHC.B2.DE120" ] ;
fhir:display [ fhir:v "Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver" ]       ] )     ] )
  ] . #